ViaCyte Secures $80M Series D Financing Posted by dumbcapital | Dec 2, 2018 | Raises and Exits, Uncategorized | 0 | SAN DIEGO, CA, Privately-held clinical stage regenerative medicine company, today announced an $80M Series D financing led by Bain Capital Life Sciences.